Top compounds associated with response to RARS


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.11 0.0007
mRNA PDMP CTRPv2 pan-cancer AAC -0.14 0.0007
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA fingolimod CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA Teniposide CTRPv2 pan-cancer AAC -0.15 0.0008
mRNA AMG-706 GDSC1000 pan-cancer AAC 0.12 0.0008
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC 0.12 0.0008
Download CSV